Rockefeller Capital Management L.P. Ptc Therapeutics, Inc. Transaction History

Rockefeller Capital Management L.P.

$36.3 Billion
Q3 2024

A detailed history of Rockefeller Capital Management L.P. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 493,588 shares of PTCT stock, worth $22.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

493,588

Previous 499,144 1.11%

Holding current value

$22.6 Million

Previous $15.3 Million 19.98%

% of portfolio

0.05%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$30.39 - $37.66 $168,846 - $209,238	-5,556 Reduced 1.11%	493,588 $18.3 Million
Q2 2024 Aug 12, 2024	SELL	$24.69 - $40.12 $26,467 - $43,008	-1,072 Reduced 0.21%	499,144 $15.3 Million
Q1 2024 May 14, 2024	SELL	$24.15 - $31.95 $24,777 - $32,780	-1,026 Reduced 0.2%	500,216 $14.6 Million
Q4 2023 Feb 14, 2024	BUY	$18.07 - $29.37 $2.23 Million - $3.62 Million	123,183 Added 32.58%	501,242 $13.8 Million
Q3 2023 Nov 14, 2023	BUY	$22.41 - $41.99 $3.71 Million - $6.96 Million	165,652 Added 77.99%	378,059 $8.47 Million
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $906,333 - $1.33 Million	22,434 Added 11.81%	212,407 $8.64 Million
Q1 2023 May 17, 2023	BUY	$38.16 - $48.86 $52,851 - $67,671	1,385 Added 0.73%	189,973 $9.2 Million
Q4 2022 Mar 06, 2023	BUY	$33.53 - $54.79 $1.15 Million - $1.89 Million	34,446 Added 22.35%	188,588 $7.2 Million
Q3 2022 Nov 02, 2022	SELL	$41.85 - $53.85 $338,692 - $435,808	-8,093 Reduced 4.99%	154,142 $7.74 Million
Q2 2022 Aug 12, 2022	BUY	$25.6 - $45.23 $381,875 - $674,695	14,917 Added 10.13%	162,235 $6.5 Million
Q1 2022 May 13, 2022	BUY	$33.33 - $44.6 $295,203 - $395,022	8,857 Added 6.4%	147,318 $5.5 Million
Q4 2021 Feb 14, 2022	BUY	$35.36 - $41.86 $273,014 - $323,201	7,721 Added 5.91%	138,461 $5.51 Million
Q3 2021 Nov 12, 2021	BUY	$37.01 - $44.74 $651,116 - $787,110	17,593 Added 15.55%	130,740 $4.86 Million
Q2 2021 Aug 10, 2021	BUY	$37.95 - $49.37 $4.29 Million - $5.59 Million	113,147 New	113,147 $4.78 Million
Q4 2020 Feb 12, 2021	SELL	$47.96 - $67.64 $133,664 - $188,512	-2,787 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$42.56 - $54.98 $25,961 - $33,537	-610 Reduced 17.96%	2,787 $141,000
Q4 2019 Feb 07, 2020	SELL	$32.22 - $50.07 $1,514 - $2,353	-47 Reduced 1.36%	3,397 $163,000
Q3 2019 Nov 12, 2019	SELL	$33.82 - $48.17 $3,246 - $4,624	-96 Reduced 2.71%	3,444 $116,000
Q1 2019 May 10, 2019	SELL	$28.09 - $39.49 $77,725 - $109,268	-2,767 Reduced 43.87%	3,540 $133,000
Q3 2018 Nov 02, 2018	BUY	$33.9 - $47.77 $213,807 - $301,285	6,307 New	6,307 $296,000

Others Institutions Holding PTCT

# of Institutions

221

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.27B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account

Rockefeller Capital Management L.P. Ptc Therapeutics, Inc. Transaction History